JAK inhibitors in autoinflammatory syndromes? The long road from drug development to daily clinical use

被引：5
|
作者：
Guilpain, Philippe [1 ,2 ,3 ]
机构：
[1] St Eloi Hosp, Dept Internal Med & Multiorgan Dis, Local Referral Ctr Syst & Autoimmune Dis, Montpellier, France
[2] Univ Montpellier, Fac Med, Montpellier, France
[3] St Eloi Hosp, Inst Regenerat Med & Biotherapy IRMB, Inserm U1183, Montpellier, France
来源：
RHEUMATOLOGY | 2023年 / 62卷 / 04期
关键词：
SAFETY;
D O I：
10.1093/rheumatology/keac592
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1368 / 1369
页数：2
相关论文
共 50 条
  • [21] JAK-STAT signaling in human disease: From genetic syndromes to clinical inhibition
    Luo, Yiming
    Alexander, Madison
    Gadina, Massimo
    O'Shea, John J.
    Meylan, Francoise
    Schwartz, Daniella M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 148 (04) : 911 - 925
  • [22] A long and winding road; evolution of antimicrobial drug development - crisis management
    Echols, Roger M.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2012, 10 (11) : 1311 - 1319
  • [23] Biomarkers for Cervical Cancer Prevention Programs: The Long and Winding Road From Discovery to Clinical Use
    Wentzensen, Nicolas
    Silver, Michelle I.
    JOURNAL OF LOWER GENITAL TRACT DISEASE, 2016, 20 (03) : 191 - 194
  • [24] Clinical efficacy of new JAK inhibitors under development. Just more of the same?
    Westhovens, Rene
    RHEUMATOLOGY, 2019, 58 : 27 - 33
  • [25] FACTORS WHICH CONTRIBUTE PERSISTENCY AND OPTIMAL USE OF TOFACITINIB; LESSONS FROM LONG TERM DAILY CLINICAL USE OF TOFACITINIB
    Iwamoto, N.
    Aramaki, T.
    Ichinose, K.
    Ueki, Y.
    Kawakami, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1467 - 1468
  • [26] Long QT and Brugada syndromes: From genetics to clinical management
    Priori, SG
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2000, 11 (10) : 1174 - 1178
  • [27] Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes
    Braunwald, E
    Maseri, A
    Armstrong, PW
    Califf, RM
    Gibler, WB
    Hamm, CW
    Simoons, ML
    Van de Werf, F
    AMERICAN HEART JOURNAL, 1998, 135 (04) : S56 - S66
  • [28] Rationale and clinical evidence for the use of GP IIb/IIIa inhibitors in acute coronary syndromes
    Braunwald, E
    Maseri, A
    Armstrong, PW
    Califf, RM
    Gibler, WB
    Hamm, CW
    Simoons, ML
    Van de Werf, F
    EUROPEAN HEART JOURNAL, 1998, 19 : D22 - D30
  • [29] From harsh daily reality to the easy fix: daily management of harmful drug use
    Pinkusfeld Bastos, Francisco Inacio
    CADERNOS DE SAUDE PUBLICA, 2017, 33 (06):
  • [30] Long-Term Safety Profile and Off-Label Use of JAK Inhibitors in Dermatological Disorders
    Corbella-Bagot, L.
    Riquelme-McLoughlin, C.
    Morgado-Carrasco, D.
    ACTAS DERMO-SIFILIOGRAFICAS, 2023, 114 (09): : T784 - T801
12345